Literature DB >> 22342492

Intact working memory in the absence of forebrain neuronal glycine transporter 1.

Sylvain Dubroqua1, Lucas Serrano, Detlev Boison, Joram Feldon, Pascual A Gargiulo, Benjamin K Yee.   

Abstract

Glycine transporter 1 (GlyT1) is a potential pharmacological target to ameliorate memory deficits attributable to N-methyl-d-aspartate receptor (NMDAR) hypofunction. Disruption of glycine-reuptake near excitatory synapses is expected to enhance NMDAR function by increasing glycine-B site occupancy. Genetic models with conditional GlyT1 deletion restricted to forebrain neurons have yielded several promising promnesic effects, yet its impact on working memory function remains essentially unanswered because the previous attempt had yielded un-interpretable outcomes. The present study clarified this important outstanding lacuna using a within-subject multi-test approach. Here, a consistent lack of effects was convincingly demonstrated across three working memory tests - the radial arm maze, the cheeseboard maze, and the water maze. These null outcomes contrasted with the phenotype of enhanced working memory performance seen in mutant mice with GlyT1 deletion extended to cortical/hippocampal glial cells. It follows that glial-based GlyT1 might be more closely linked to the modulation of working memory function, and raises the possibility that neuronal and glial GlyT1 may regulate cognitive functions via dissociable mechanisms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342492      PMCID: PMC3565836          DOI: 10.1016/j.bbr.2012.01.061

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  29 in total

1.  CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain.

Authors:  I Dragatsis; S Zeitlin
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

Review 2.  Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises.

Authors:  Jesus Gomeza; Koji Ohno; Heinrich Betz
Journal:  Curr Opin Drug Discov Devel       Date:  2003-09

3.  Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

Authors:  Neil Collinson; Frederick M Kuenzi; Wolfgang Jarolimek; Karen A Maubach; Rosa Cothliff; Cyrille Sur; Alison Smith; Franklin M Otu; Owain Howell; John R Atack; Ruth M McKernan; Guy R Seabrook; Gerry R Dawson; Paul J Whiting; Thomas W Rosahl
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 4.  The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

Authors:  P L Wood
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

5.  Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition.

Authors:  Hanns Möhler; Detlev Boison; Philipp Singer; Joram Feldon; Meike Pauly-Evers; Benjamin K Yee
Journal:  Biochem Pharmacol       Date:  2011-02-17       Impact factor: 5.858

6.  Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5.

Authors:  R G Morris
Journal:  J Neurosci       Date:  1989-09       Impact factor: 6.167

7.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

8.  GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear.

Authors:  Benjamin K Yee; Jonas Hauser; Vadim V Dolgov; Ruth Keist; Hanns Möhler; Uwe Rudolph; Joram Feldon
Journal:  Eur J Neurosci       Date:  2004-10       Impact factor: 3.386

9.  Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.

Authors:  Guochuan Tsai; Rebecca J Ralph-Williams; Marzia Martina; Richard Bergeron; Joanne Berger-Sweeney; Kevin S Dunham; Zhichun Jiang; S Barak Caine; Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

10.  Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice.

Authors:  Takuji Iwasato; Ryochi Nomura; Reiko Ando; Toshio Ikeda; Mika Tanaka; Shigeyoshi Itohara
Journal:  Genesis       Date:  2004-03       Impact factor: 2.487

View more
  2 in total

Review 1.  A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.

Authors:  Benjamin K Yee; Philipp Singer
Journal:  Cell Tissue Res       Date:  2013-04-12       Impact factor: 5.249

Review 2.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.